ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

ADMA Biologics, Inc. (ADMA)

Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)

$11.01-0.22 (-1.96%)

As of Oct 21, 4:00 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow ADMA in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on ADMA and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free ADMA chart →

ADMA at a glance

Key statistics

$2.52B

Market capitalization

Previous close
$11.23
Open
$11.17
Day range
$10.93 – $11.28
Volume
2.01M
Average volume (30 sessions)
3.21M
Shares outstanding
223.98M
Price / earnings
14.9
Earnings per share
$0.75
Price / book
6.2
Price / sales
4.9
Beta (1 year, vs SPY)
0.79

Where the price sits in its year

52-week range

29% of the range

Below the 52-week high
-46.2%
Above the 52-week low
+52.7%

Completed sessions through Oct 21, 2026

Technical snapshot

Above its 50-day average, below its 200-day

20-day average
$10.27+7.2%
50-day average
$9.78+12.6%
200-day average
$11.20-1.7%
RSI (14)66.5

Between the conventional 30 and 70 bands.

+6.5%

1 week

+12.2%

1 month

+31.5%

3 months

-39.6%

Year to date

-25.1%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with ADMA

From the public news wire

ADMA headlines

Market news →

No headlines on the wire for ADMA in recent weeks.

SEC Form 4, most recent first

Insider filings

How to read these →
  • Kestenberg-Messina Kaitlin M.

    −3.2K

    COO and SVP, Compliance · Shares withheld for tax

    $26.59K · Jul 24, 2026

  • Kohler Terry

    +85.1K

    CFO and Treasurer · Grant or award

    · Jul 16, 2026

  • Kohler Terry

    +136.4K

    CFO and Treasurer · Grant or award

    · Jul 16, 2026

  • Grossman Jerrold B

    +6.4K

    Director · Open-market purchase

    $50.62K · May 27, 2026

  • Grossman Jerrold B

    +12.5K

    Director · Open-market purchase

    $100.13K · May 12, 2026

  • Grossman Jerrold B

    +12.5K

    Director · Open-market purchase

    $100.13K · May 11, 2026

  • Kestenberg-Messina Kaitlin M.

    −20.4K

    COO and SVP, Compliance · Shares withheld for tax

    $185.50K · Apr 1, 2026

  • Guiheen Lawrence P.

    −30.0K

    Director · Gift

    · Mar 17, 2026

About ADMA Biologics, Inc.

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Exchange
Nasdaq
Security
Common stock
Industry
Biological Products, (no Diagnostic Substances)
Headquarters
Ramsey, NJ
Employees
647
Listed since
Oct 17, 2013
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.